Immediate Impact
1 by Nobel laureates 2 from Science/Nature 61 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
2025 Standout
Works of Jiang Liu being referenced
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective
2022
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jiang Liu | 146 | 410 | 420 | 216 | 40 | 1.4k | |
| Sukyung Woo | 370 | 1015 | 451 | 246 | 62 | 2.1k | |
| Daniel F. Hoth | 243 | 522 | 666 | 94 | 56 | 1.8k | |
| Dinesh P. de Alwis | 206 | 512 | 879 | 177 | 37 | 1.5k | |
| Maurie Markman | 244 | 282 | 466 | 82 | 86 | 1.5k | |
| Maria Palmisano | 148 | 489 | 379 | 170 | 85 | 1.4k | |
| B Leyland-Jones | 193 | 415 | 842 | 75 | 42 | 1.7k | |
| Haleh Saber | 182 | 613 | 591 | 209 | 20 | 1.5k | |
| Akintunde Bello | 576 | 440 | 870 | 225 | 70 | 1.7k | |
| Schabel Fm | 332 | 766 | 928 | 118 | 60 | 2.0k | |
| Margaret Whitacre | 331 | 360 | 745 | 90 | 34 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...